These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome. Lobo RA, Goebelsmann U, Horton R. J Clin Endocrinol Metab; 1983 Aug; 57(2):393-7. PubMed ID: 6223045 [Abstract] [Full Text] [Related]
3. Hirsutism and virilism in women. Kirschner MA. Spec Top Endocrinol Metab; 1984 Aug; 6():55-93. PubMed ID: 6084314 [Abstract] [Full Text] [Related]
4. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS. Cupisti S, Dittrich R, Binder H, Kajaia N, Hoffmann I, Maltaris T, Beckmann MW, Mueller A. Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884 [Abstract] [Full Text] [Related]
5. Androgen and estrogen formation in women with ovarian hyperthecosis. Aiman J, Edman CD, Worley RJ, Vellios F, MacDonald PC. Obstet Gynecol; 1978 Jan; 51(1):1-9. PubMed ID: 619322 [Abstract] [Full Text] [Related]
6. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects. Meczekalski B, Slopien R, Warenik-Szymankiewicz A. Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812 [Abstract] [Full Text] [Related]
7. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation. Sobbrio GA, Granata A, D'Arrigo F, Arena D, Panacea A, Trimarchi F, Granese D, Pullè C. Acta Eur Fertil; 1990 May; 21(3):139-41. PubMed ID: 2149912 [Abstract] [Full Text] [Related]
8. Disturbances of androgen secretion and metabolism in polycystic ovary syndrome. Lobo RA. Clin Obstet Gynaecol; 1985 Sep; 12(3):633-47. PubMed ID: 2933204 [Abstract] [Full Text] [Related]
9. The relation between obesity and testosterone-estradiol binding globulin levels in polycystic ovarian syndrome (PCO). Badawy SZ, Weigert JM, Marshall LD, Cuenca VG. Diagn Gynecol Obstet; 1980 Sep; 2(1):43-6. PubMed ID: 7193560 [Abstract] [Full Text] [Related]
10. Effect of obesity on the clinical and hormonal characteristics of the polycystic ovary syndrome. Singh KB, Mahajan DK, Wortsman J. J Reprod Med; 1994 Oct; 39(10):805-8. PubMed ID: 7837128 [Abstract] [Full Text] [Related]
11. [Value of laboratory parameters in androgenization in the female with special reference to the "free androgen index"]. Urdl W, Schweditsch MO, Kowatsch AW, Tscherne G, Pürstner P, Haas J. Geburtshilfe Frauenheilkd; 1986 Oct; 46(10):743-7. PubMed ID: 2948867 [Abstract] [Full Text] [Related]
12. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome. Barber TM, Wass JA, McCarthy MI, Franks S. Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468 [Abstract] [Full Text] [Related]
13. Testosterone environment of splenocytes modifies the steroidogenesis of polycystic ovary in rats. Forneris M, Rosales E, Ciuffo G, Oliveros L. Horm Metab Res; 2008 Apr; 40(4):239-44. PubMed ID: 18256972 [Abstract] [Full Text] [Related]
17. Effectiveness of different diagnostic methods for assessment of hyperandrogenism in young women with hirsutism. Chanukvadze D, Kristesashvili J. Georgian Med News; 2011 Nov; 11(200):25-9. PubMed ID: 22201076 [Abstract] [Full Text] [Related]
19. Endocrinological markers for assessing hyperandrogenemia in women classified as having polycystic ovary syndrome (PCOS) according to the revised 2003 diagnostic criteria. Mueller A, Dittrich R, Binder H, Hoffmann I, Beckmann MW, Cupisti S. Eur J Med Res; 2006 Dec 14; 11(12):540-4. PubMed ID: 17182367 [Abstract] [Full Text] [Related]